The DOI matches its Crossref record; 41 of the 42 references it cites were found in a registry or an index.
In Vivo D2 Dopamine Receptor Density in Psychotic and Nonpsychotic Patients With Bipolar Disorder
Abstract
BACKGROUND: A prior positron emission tomographic study from The Johns Hopkins University, Baltimore, Md, using N-methylspiperone labeled with carbon 11 reported elevated basal ganglia D2 dopamine receptor density (Bmax) values in neuroleptic-naive schizophrenic patients compared with controls. We have now extended these studies to include patients with bipolar disorder. METHODS: Patients with bipolar disorder (n = 14) either had never received neuroleptic medication or had been neuroleptic-free for more than 6 months, and they met DSM-III criteria for currently symptomatic affective disorder. Patients with bipolar disorder were compared with matched schizophrenic patients and normal controls. All received two positron emission tomographic scans, the second of which was preceded by oral administration of haloperidol lactate, to permit the calculation of D2 dopamine receptor Bmax. RESULTS: Diagnostic groups differed in Bmax by analysis of variance (P < .0001); post hoc tests showed higher Bmax values for psychotic patients with bipolar disorder and schizophrenic patients compared with normal controls and for schizophrenic patients and psychotic patients with bipolar disorder compared with nonpsychotic patients with bipolar disorder. Among patients with bipolar disorder, Bmax values correlated significantly with the severity of psychotic symptoms (r = .63) on the Present State Examination but not with the severity of nonpsychotic mood symptoms. CONCLUSIONS: We conclude that, like schizophrenic patients, patients with psychotic bipolar disorder have elevations of D2 dopamine receptor Bmax values and that such elevations in affective disorder are more closely associated with the presence of psychosis than with mood abnormality. Elevations in dopamine receptor values thus may occur in psychiatric states that are characterized by psychotic symptoms rather than being specific to schizophrenia.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is also evidence that the presence of psychosis may moderate patterns of DA receptor binding. Specifically, striatal D2 receptor signaling seems to be greater in psychotic patients with bipolar disorder [286,287], whereas no differences in D2 availability were found between non-psychotic patients with bipolar disorder and controls [288,289].”
From Reward circuitry dysfunction in psychiatric and neurodevelopmental disorders and genetic syndromes: animal models and clinical findings (2012) · cites this paper as [286]
Citations
Cites
Folstein, M. F., Folstein, S. E., & McHugh, P. R. (1975) · Journal of Psychiatric Research · doi:10.1016/0022-3956(75)90026-6 · Cited by 88,282
Hamilton, M. (1960) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.23.1.56 · Cited by 32,817
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
A Rating Scale for Mania: Reliability, Validity and Sensitivity
Young, R. C., Biggs, J. T., Ziegler, V. E., & Meyer, D. A. (1978) · British Journal of Psychiatry · doi:10.1192/bjp.133.5.429 · Cited by 8,744
Book Review: Measurement and Classification of Psychiatric Symptoms
Priest, R. G. (1975) · Proceedings of the Royal Society of Medicine · doi:10.1177/003591577506800751 · Cited by 2,268
Positron Emission Tomography Reveals Elevated D 2 Dopamine Receptors in Drug-Naive Schizophrenics
Wong, D. F., Wagner, H. N., Tune, L. E., Dannals, R. F., Pearlson, G. D., Links, J. M., Tamminga, C. A., Broussolle, E., Ravert, H. T., Wilson, A. A., et al. (1986) · Science · doi:10.1126/science.2878495 · Cited by 928
Self-citationWong, D. F., Wagner, H. N., Dannals, R. F., Links, J. M., Frost, J. J., Ravert, H. T., Wilson, A. A., Rosenbaum, A. E., GJEDDE, A. H., Douglass, K. H., et al. (1984) · Science · doi:10.1126/science.6334363 · Cited by 700
Swerdlow, N. R., & Koob, G. F. (1987) · Behavioral and Brain Sciences · doi:10.1017/s0140525x00047488 · Cited by 674
Diagnosis in Schizophrenia and Manic-Depressive Illness
Pope, H. G. (1978) · Archives of General Psychiatry · doi:10.1001/archpsyc.1978.01770310017001 · Cited by 630
Dopamine D4 receptors elevated in schizophrenia
Seeman, P. M., Guan, H., & Tol, H. H. M. V. (1993) · Nature · doi:10.1038/365441a0 · Cited by 627
Cited by
Sorted by citations
Items 101–200 of 235
Mood and behavior regulation: interaction of lithium and dopaminergic system
Mohamadian, M., Fallah, H., Ghofrani-Jahromi, Z., Rahimi-Danesh, M., Saadlou, M.-S. S. Q., & Vaseghi, S. (2023) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-023-02437-1 · Cited by 33
Linkage of mood disorders with D2, D3 and TH genes: a multicenter study
Serretti, A., Macciardi, F. M., Cusin, C., Lattuada, E., Souery, D., Lipp, O., Mahieu, B., Broeckhoven, C. V., Blackwood, D., Muir, W. J., et al. (2000) · Journal of Affective Disorders · doi:10.1016/s0165-0327(99)00112-3 · Cited by 31
Brain imaging of affective disorders and schizophrenia
Kishimoto, H., Yamada, K., Iseki, E., Kosaka, K., & OKOSHI, T. (1998) · Psychiatry and Clinical Neurosciences · doi:10.1111/j.1440-1819.1998.tb03224.x · Cited by 31
Dean, B. (2012) · Current Topics in Medicinal Chemistry · doi:10.2174/156802612805289935 · Cited by 30
Nader, M. A. (1999) · Neuropsychopharmacology · doi:10.1016/s0893-133x(98)00101-8 · Cited by 29
Yatham, L. N., Liddle, P. F., Gonzalez, M., Saraf, G., Vafai, N. M., Lam, R. W. M., & Sossi, V. (2022) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2022.3541 · Cited by 26
Belli, S. R. (2009) · Personality and Individual Differences · doi:10.1016/j.paid.2009.01.016 · Cited by 28
No association between dopamine D1, D2, and D3 receptor genes and manic–depressive illness
Savoye, C., Laurent‐Levinson, C., Amadéo, S., Gheysen, F., Leboyer, M., Lejeune, J., Zarifian, E., & Mallet, J. J. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00441-1 · Cited by 28
Positron emission tomography in psychiatric disorders
Newberg, A. B., Moss, A., Monti, D., & Alavi, A. A. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2011.06162.x · Cited by 29
GJEDDE, A. H., & Wong, D. F. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200108000-00011 · Cited by 27
Neuroimaging and Neuropathological Studies of Mood Disorders
Drevets, W. C., & Price, J. L. (2005) · Biology of Depression · doi:10.1002/9783527619672.ch17 · Cited by 26
A Rating Scale for Psychotic Symptoms (RSPS)
Chouinard, G., & Miller, R. (1999) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00012-2 · Cited by 26
Nikolaus, S., Hautzel, H., & Müller, H. (2014) · Reviews in the Neurosciences · doi:10.1515/revneuro-2013-0063 · Cited by 26
Pradier, M. D., Gorwood, P. A. P. M., Beaufils, B., Adès, J., & Dubertret, C. (2010) · European Psychiatry · doi:10.1016/j.eurpsy.2009.10.002 · Cited by 25
Chronic Treatment with Mood Stabilizers Increases Membrane GRK3 in Rat Frontal Cortex
Ertley, R. N., Bazinet, R. P., Lee, H., Rapoport, S. I., & Rao, J. S. (2006) · Biological Psychiatry · doi:10.1016/j.biopsych.2006.03.022 · Cited by 25
120th Anniversary of the Kraepelinian Dichotomy of Psychiatric Disorders
Rybakowski, J. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1048-6 · Cited by 22
Antipsychotics in the Treatment of Bipolar Disorder
Singh, J. B., Chen, G., & Canuso, C. M. (2012) · Handbook of experimental pharmacology · doi:10.1007/978-3-642-25761-2_8 · Cited by 25
Neuroimaging Bipolar Illness With Positron Emission Tomography and Magnetic Resonance Imaging
Buchsbaum, M. S., Someya, T., Wu, J. C., Tang, C. Y., & Bunney, W. E. (1997) · Psychiatric Annals · doi:10.3928/0048-5713-19970701-10 · Cited by 24
Ramadan, E., Basselin, M., Taha, A. Y., Cheon, Y., Chang, L., Chen, M., & Rapoport, S. I. (2011) · Neuropharmacology · doi:10.1016/j.neuropharm.2011.07.025 · Cited by 24
Hamm, J. P., Ethridge, L. E., Shapiro, J. R., Pearlson, G. D., Tamminga, C. A., Sweeney, J. A., Keshavan, M. S., Thaker, G. K., & Clementz, B. A. (2013) · Bipolar Disorders · doi:10.1111/bdi.12110 · Cited by 24
Self-citationThe prolactin response to sulpiride in major depression: the role of the D2 receptor in depression
Verbeeck, W., Berk, M., Paiker, J., & Jersky, B. (2001) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(01)00086-4 · Cited by 25
Imaging strategies in depression
Grasby, P. M. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300407 · Cited by 23
D’Urso, G., Toscano, E., Barone, A., Palermo, M., Dell’Osso, B. M., Lorenzo, G. D., Mantovani, A., Martinotti, G., Fornaro, M., Iasevoli, F., et al. (2022) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2022.110672 · Cited by 25
Role ofDRD2andALDH2genes in bipolar II disorder with and without comorbid anxiety disorder
Wang, Y.-S., Lee, S.-Y., Chen, S.-L., Chang, Y.-H., Wang, T.-T., Lin, S.-H., Wang, C.-L., Huang, S.-Y., Lee, I. H., Chen, P. S., et al. (2013) · European Psychiatry · doi:10.1016/j.eurpsy.2013.05.001 · Cited by 21
Decreased GRK3 but not GRK2 expression in frontal cortex from bipolar disorder patients
Rao, J. S., Rapoport, S. I., & Kim, H. (2009) · The International Journal of Neuropsychopharmacology · doi:10.1017/s146114570900025x · Cited by 22
RetractedBehavioral Neurobiology of Bipolar Disorder and its Treatment
Manji, H. K., & Zarate, C. A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/978-3-642-15757-8 · Cited by 20
Altered brain activation during reward anticipation in bipolar disorder
Long, X., Wang, X., Tian, F., Cao, Y., Xie, H., & Jia, Z. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02075-w · Cited by 22
Cortical instability and the mechanism of mania: a neural network simulation and perceptual test
Hoffman, R. E., Quinlan, D. M., Mazure, C. M., & McGlashan, T. H. (2001) · Biological Psychiatry · doi:10.1016/s0006-3223(00)01071-4 · Cited by 19
Clinical Diagnosis: A Marker for Disease?
Tien, A. Y., & Gallo, J. J. (1997) · The Journal of Nervous and Mental Disease · doi:10.1097/00005053-199712000-00004 · Cited by 18
Changes in striatal dopamine transporters in bipolar disorder and valproate treatment
Hsueh, Y., Lin, C.-Y., Chiu, N.-T., Yang, Y. K., Chen, P. S., & Chang, H. H. (2021) · European Psychiatry · doi:10.1192/j.eurpsy.2021.1 · Cited by 17
In vivo imaging of neurotransmitter systems in neuropsychiatry
Wong, D. F., & Brašić, J. R. (2001) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(00)00005-0 · Cited by 17
Park, J., Ayduk, Ö. N., O’Donnell, L. A., Chun, J., Gruber, J., Kamali, M., McInnis, M. G., Deldin, P. J., & Kross, E. F. (2014) · Clinical Psychological Science · doi:10.1177/2167702614527580 · Cited by 18
Solmi, M., Bodini, L., Cocozza, S., Seeman, M. V., Vieta, E., Dragioti, E., Carvalho, A. F., & Fusar‐Poli, P. (2020) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2020.09.635 · Cited by 17
Neurobiology of treatment-resistant schizophrenia: new insights and new models
Beerpoot, L. J., Lipska, B. K., & Weinberger, D. R. (1996) · European Neuropsychopharmacology · doi:10.1016/0924-977x(96)00008-9 · Cited by 16
Evers, S. S., van Vliet, A., van Vugt, B., Scheurink, A. J. W., & van Dijk, G. (2016) · Psychoneuroendocrinology · doi:10.1016/j.psyneuen.2015.12.024 · Cited by 15
Squarzoni, P., Duran, F., Busatto, G. F., & Alves, T. C. T. F. (2018) · Journal of Alzheimer s Disease · doi:10.3233/jad-161036 · Cited by 15
A Personal History of Nuclear Medicine
(2007) · Radiology · doi:10.1148/radiol.2452072541 · Cited by 15
Can brain-imaging studies provide a ‘mood stabilizer signature?’
Soares, J. C. (2002) · Molecular Psychiatry · doi:10.1038/sj.mp.4001020 · Cited by 15
Demontis, F., Serra, F., & Serra, G. (2016) · Current Neuropharmacology · doi:10.2174/1570159x14666160715165648 · Cited by 15
Predictive Pursuit Association with Deficits in Working Memory in Psychosis
Moates, A. F., Ivleva, E. I., O’Neill, H., Krishna, N., Cullum, C. M., Thaker, G. K., & Tamminga, C. A. (2012) · Biological Psychiatry · doi:10.1016/j.biopsych.2012.03.030 · Cited by 17
Johnson, W. G. (1999) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(19990820)88:4 · Cited by 33
Lieberman, D. Z., Kolodner, G., Massey, S. H., & Williams, K. P. (2009) · Journal of Addictive Diseases · doi:10.1080/10550880903182994 · Cited by 13
Hirasawa-Fujita, M., Bly, M. J., Ellingrod, V. L., Dalack, G. W., & Domino, E. F. (2014) · Clinical Schizophrenia & Related Psychoses · doi:10.3371/csrp.mhmb.061314 · Cited by 12
Neuroreceptor Imaging of Stress and Mood Disorders
Kennedy, S. E., & Zubieta, J.-K. (2004) · CNS Spectrums · doi:10.1017/s1092852900009238 · Cited by 12
Spiegel, D. R., Weller, A. L., Pennell, K. N., & Turner, K. (2010) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.22.1.111 · Cited by 12
The Role of the Aminergic Systems in the Pathophysiology of Bipolar Disorder
Walderhaug, E., Varga, M., Pedro, M. S., Hu, J., & Neumeister, A. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_72 · Cited by 12
Ketter, T. A., & Drevets, W. C. (2002) · Clinical Neuroscience Research · doi:10.1016/s1566-2772(02)00043-9 · Cited by 13
Translating knowledge of genetics and pharmacology into improving everyday practice
Yatham, L. N. (2005) · Bipolar Disorders · doi:10.1111/j.1399-5618.2005.00211.x · Cited by 12
Martins, M. J. R. V., Castilho, P., Carvalho, C. B., Pereira, A. T., Santos, V., Gumley, A., & de Macedo, A. F. (2017) · European Psychologist · doi:10.1027/1016-9040/a000283 · Cited by 11
Molecular Imaging of Depressive Disorders
Ruhé, H. G., Visser, A. K. D., Frøkjær, V. G., Haarman, B. C. M., Klein, H. C., & Booij, J. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_5 · Cited by 11
de Sousa, T. R., Correia, D. T., & Novais, F. (2021) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1871527320666210902164235 · Cited by 10
Neurochemical brain imaging studies in bipolar disorder
Yatham, L. N., & Malhi, G. S. (2003) · Acta Neuropsychiatrica · doi:10.1046/j.1601-5215.2003.00053.x · Cited by 10
Genetic evidence for the “dopamine hypothesis of bipolar disorder”
Zhang, C., Cai, X., Guo, L., Wang, L., Liu, Z., Luo, X., Li, M., Dou, Z., Guan, S., Guo, T., et al. (2022) · Molecular Psychiatry · doi:10.1038/s41380-022-01808-z · Cited by 9
Biology and recent brain imaging studies in affective psychoses
Wang, P. W., & Ketter, T. A. (2000) · Current Psychiatry Reports · doi:10.1007/s11920-000-0071-x · Cited by 9
Appleberg, B., Katila, H., & Rimón, R. (2000) · Schizophrenia Research · doi:10.1016/s0920-9964(99)00195-4 · Cited by 9
Taylor, E. H. (2006) · CRC Press eBooks · doi:10.3109/9780203490754 · Cited by 9
Pushing the Frontiers: Optogenetics for Illuminating the Neural Pathophysiology of Bipolar Disorder
Kong, L., Guo, X., Shen, Y., Xu, L., Huang, H., Lu, J., & Hu, S. (2023) · International Journal of Biological Sciences · doi:10.7150/ijbs.84923 · Cited by 9
Efficacy and tolerability of injectable sodium valproate in patients with mania
Solanki, R., Singh, P., Khandelwal, R., & Midha, A. (2006) · Indian Journal of Psychiatry · doi:10.4103/0019-5545.31603 · Cited by 8
Homeostatic disruption and depression
Naisberg, Y. (1996) · Medical Hypotheses · doi:10.1016/s0306-9877(96)90152-8 · Cited by 7
Role of PET in the Investigation of Neuropsychiatric Disorders
Newberg, A. B., & Alavi, A. A. (2010) · PET Clinics · doi:10.1016/j.cpet.2010.03.003 · Cited by 8
Neuroimaging Studies of Mood Disorders
Walsh, N., & Drevets, W. C. (2003) · CRC Press eBooks · doi:10.3109/9780203508343-6 · Cited by 6
Signal Transduction Pathways in the Pathophysiology of Bipolar Disorder
Gawryluk, J. W., & Young, L. T. (2010) · Current topics in behavioral neurosciences · doi:10.1007/7854_2010_71 · Cited by 6
Abnormalities in Catecholamines and the Pathophysiology of Bipolar Disorder
Garakani, A., Charney, D. S., & Anand, A. (2007) · CRC Press eBooks · doi:10.3109/9781420021158-6 · Cited by 6
Ayres, A. M. (2009) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2009.tde-27082009-154755 · Cited by 6
Ma, S., Ma, Q., Hu, S., Mo, X., Zhu, C., Zhang, X., Jia, Z., Jiang, L., Jiang, L., Cui, Y., et al. (2024) · Cell Reports · doi:10.1016/j.celrep.2024.114717 · Cited by 5
Altered brain dopamine metabolism is a trait marker for bipolar disorder
Pålsson, E., Sellgren, C. M., Pelanis, A., Zetterberg, H., Blennow, K., & Landén, M. (2023) · Biomarkers in Neuropsychiatry · doi:10.1016/j.bionps.2023.100078 · Cited by 6
Pae, C., Marks, D. M., Han, C., & Patkar, A. A. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.02.011 · Cited by 5
Positron emission tomography in neurological and psychiatric disorders
Newberg, A. B., Monti, D., Moss, A., & Alavi, A. A. (2012) · International Journal of Imaging Systems and Technology · doi:10.1002/ima.22004 · Cited by 3
An Overview of Machine Learning Applications in Mood Disorders
Topolski, N., Jeong, S. H., & Mwangi, B. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.017 · Cited by 4
Molecular Imaging of Depressive Disorders
Ruhé, H. G., Frøkjær, V. G., Haarman, B. C. M., Jacobs, G. E., & Booij, J. (2020) · Springer eBooks · doi:10.1007/978-3-030-57231-0_4 · Cited by 3
Neurotransmitter Systems in Bipolar Disorder
Nakic, M., Krystal, J. H., & Bhagwagar, Z. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch16 · Cited by 4
Elevated lymphocyte spiperone binding: A vulnerability factor for affective psychosis?
Fartacek, R. R., Geretsegger, C., Breitfuss, A., Ackenheil, M., & Bondy, B. (1997) · Biological Psychiatry · doi:10.1016/s0006-3223(96)00383-6 · Cited by 4
Brain Age Disparities in Psychosis Across DSM Diagnoses and B-SNIP Biotypes
Promet, L., Meda, S. A., Alliey‐Rodriguez, N., Clementz, B. A., Gershon, E. S., Hill, S. K., Ivleva, E. I., Keedy, S., Keshavan, M. S., McDowell, J. E., et al. (2025) · Schizophrenia Bulletin · doi:10.1093/schbul/sbaf022 · Cited by 3
Self-citationSaraf, G., Pinto, J. V., Cahn, A. J., White, A. G., Shahinfard, E., Vafai, N. M., Sossi, V., & Yatham, L. N. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.022 · Cited by 3
Haarman, B. C. M., der Lek, R. F. R., Ruhé, H. G., de Groot, J. C., Nolen, W. A., & Doorduin, J. (2014) · Springer eBooks · doi:10.1007/978-3-642-40384-2_9 · Cited by 3
(2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018 · Cited by 3
The neurobiology of Bipolar II disorder
Bora, E., & Pantelis, C. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139003315.010 · Cited by 3
Are There Connections between the Neuroendocrine and Dopamine Systems in Bipolar Disorder?
Trouillas, J., Claustrat, B., Henry, E., Lemius, J., Alafuzoff, I. I., & Nataf, S. (2025) · Neuroendocrinology · doi:10.1159/000547042 · Cited by 2
Neuroimaging Studies of Effects of Psychotherapy in Depression
Bauer, I. E., & Meyer, T. D. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.021 · Cited by 2
Electrophysiological Biomarkers for Mood Disorders
Ramakrishnan, N., Murphy, N., Selvaraj, S., & Cho, R. Y. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.015 · Cited by 2
Abnormalities in Catecholamines and the Pathophysiology of Bipolar Disorder
Garakani, A., Charney, D. S., & Anand, A. (2007) · Medical psychiatry · doi:10.3109/9781420021158.003 · Cited by 2
Schmerder, K., & Freund, N. (2022) · Neuromethods · doi:10.1007/978-1-0716-2748-8_13 · Cited by 2
Neuroimaging studies of bipolar depression: therapeutic implications
Savitz, J. B., & Drevets, W. C. (2009) · Birkhäuser Basel eBooks · doi:10.1007/978-3-7643-8567-5_8 · Cited by 2
Neuroimaging Studies of Bipolar Depression: Therapeutic Implications
Savitz, J. B., Morris, H. M., & Drevets, W. C. (2016) · Milestones in drug therapy · doi:10.1007/978-3-319-31689-5_8 · Cited by 2
Phenomenology and Clinical Science of Schizophrenia
Ghose, S., & Tamminga, C. A. (2007) · Wiley eBooks · doi:10.1002/9780470101001.hcn029 · Cited by 2
Molecular Biology of Bipolar Disorder
Andreazza, A. C., Wang, J. F., & Young, T. (2010) · Wiley eBooks · doi:10.1002/9780470661277.ch17 · Cited by 2
Brain Imaging and Function — The Balance of the Century
Johnstone, E. C. (1999) · Steinkopff eBooks · doi:10.1007/978-3-642-47076-9_21 · Cited by 2
Malhotra, G., Kasaliwal, R., Rupani, K., Lila, A. R., Upadhye, T. S., Bandgar, T., & Shah, N. S. (2024) · Clinical Nuclear Medicine · doi:10.1097/rlu.0000000000005531 · Cited by 1
An assessment of the catecholamine hypothesis of bipolar disorder
Charney, A. W., Sayed, S., & Charney, D. S. (2016) · Cambridge University Press eBooks · doi:10.1017/cbo9781107477278.004 · Cited by 1
Brain Imaging and the Mechanisms of Antidepressant Action
Godlewska, B. R., Selvaraj, S., & Cowen, P. J. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.020 · Cited by 1
Effects of Lithium on Brain Structure in Bipolar Disorder
Kaur, J., Kafantaris, V., & Szeszko, P. R. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.018 · Cited by 1
Functional Connectome in Bipolar Disorder
Cha, J., & Anand, A. (2021) · Cambridge University Press eBooks · doi:10.1017/9781108623018.008 · Cited by 1
Biologic Factors in Different Bipolar Disorder Subtypes
Cerullo, M. A., & Strakowski, S. M. (2007) · Medical psychiatry · doi:10.3109/9781420021158.017 · Cited by 1
Biologiset tekijät kaksisuuntaisessa mielialahäiriössä
Partonen, T. (1999) · STM:n Hallinnonalan avoin julkaisuarkisto (Julkari)
Onset, course and comorbidity of bipolar symptoms in population and treatment settings
Rossum, I. W.-V. (2010) · Research Publications (Maastricht University) · doi:10.26481/dis.20100114ir
Attention-deficit hyperactivity disorder in bipolar disorder
Rydén, E. (2010) · Figshare
Konzeption und Grundlagen einer funktionalen Psycho pharmako therapie
Gründer, G., & Benkert, O. (2011) · Springer eBooks · doi:10.1007/978-3-642-19844-1_1
Molecular imaging of bipolar illness
Brooks, J. O., Wang, P. W., & Ketter, T. A. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511782091.009
Clark, D. L., Boutros, N. N., & Mendez, M. F. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511543661.008
Positron emissie tomografie (PET) bij stemmingsstoornissen: een overzicht
Eyken, N. V., & D’Haenen, H. (1999) · Acta Neuropsychiatrica · doi:10.1017/s0924270800036048
Metadata
- Authors
- Pearlson, G. D.
- Affiliations
- Johns Hopkins University (US)
- Corresponding author
- Pearlson, Godfrey D.
- ORCID
- Pearlson, Godfrey D.
- Venue
- Archives of General Psychiatry
- Publisher
- American Medical Association (AMA)
- Published
- 1995-06-01
- Volume
- 52
- Issue
- 6
- Pages
- 471
- ISSN
- 0003-990X (ISSN-L)
- OpenAlex
- W2138538568
- Cited by
- 235
- References
- 42
- Citations by year
- 2026: 2 · 2025: 3 · 2024: 2 · 2023: 3 · 2022: 6 · 2021: 27 · 2020: 3 · 2019: 4 · 2018: 3 · 2017: 7 · 2016: 6 · 2015: 4 · 2014: 13 · 2013: 6 · 2012: 15
- FWCI
- 7.55
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Archives of General Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01mh040391-02, 5r01mh042821-07)
- National Institute of Mental Health (MH 42821, MH-40391, MH43775)
- Topics
- Health Sciences › Medicine › Psychiatry and Mental health › Bipolar Disorder and Treatment
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Keywords
- bipolar disorder, psychosis, schizophrenia, basal ganglia, neuroleptic-naive patients, psychotic symptom severity, dopamine receptor binding
- MeSH terms
- Adult, Bipolar Disorder, Brain, Carbon Radioisotopes, Caudate Nucleus, Female, Haloperidol, Humans, Male, Middle Aged, Psychiatric Status Rating Scales, Psychotic Disorders, Putamen, Receptors, Dopamine, Schizophrenia, Spiperone, Tomography, Emission-Computed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review